Decreased incidence of late-onset sepsis during the SARS-CoV-2 pandemic in Italy: a multicentric study on a cohort of infants requiring major surgery.


Journal

European journal of pediatrics
ISSN: 1432-1076
Titre abrégé: Eur J Pediatr
Pays: Germany
ID NLM: 7603873

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 17 05 2023
accepted: 30 07 2023
revised: 12 07 2023
medline: 13 11 2023
pubmed: 16 8 2023
entrez: 15 8 2023
Statut: ppublish

Résumé

Changes in the organization of the clinical care wards, requested by the SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) pandemic, have influenced the environmental circulation of other pathogens. The implementation of prevention procedures may have led to a decrease in the incidence of healthcare-associated infections. We aimed to investigate the impact of prevention and control measures for preventing the COVID-19 spread on the incidence of bacterial sepsis and invasive fungal infections in neonates and infants requiring major surgery. We compared the incidence of bacterial and fungal sepsis and their risk factors observed before the SARS-CoV-2 pandemic (from 01/10/2018 to 29/02/2020) with those observed during the pandemic (from 01/03/2020 to 07/05/2021) in 13 level III Neonatal Intensive Care Units in Italy, through a secondary analysis of data, collected during a prospective multicenter study (REF). The patients enrolled were infants within three months of life, hospitalized in the two periods in the participating centers to undergo major surgery. Among 541 enrolled patients, 324 (59.9%) were born in the pre-pandemic period and 217 (40.1%) during the pandemic. The incidence density (ID) of any infection in the pre-pandemic period was 16.0/1000 patient days versus 13.6/1000 patient days in the pandemic period (p < 0.001). One hundred and forty-five (145/324; 44.8%) patients developed at least one episode of bacterial sepsis in the pre-pandemic period, versus 103/217 (31.8%) patients, during the pandemic (p = 0.539). Concerning fungal sepsis, 12 (3.7%) patients had one episode in the pre-pandemic period versus 11 (5.1%) patients during the pandemic (p = 0.516). The most significant differences observed in the use of healthcare procedures were the reduction of CVC days, the reduced use of antibiotics pre-surgery, and that of proton pump inhibitors during the SARS-CoV-2 pandemic compared with the previous period. In our cohort of patients with major surgical needs, the reduction of CVC days, pre-surgery antibiotics administration, and current use of proton pump inhibitors, during the SARS-CoV-2 pandemic, led to a decrease in the incidence of late-onset sepsis. • Most cases of late-onset sepsis in neonates are referred to as central line-associated bloodstream infections. • In adults, the COVID-19 outbreak negatively influenced healthcare-associated infection rates and infection clusters within hospitals. • In neonates and infants undergoing major surgery the incidence density of infections was lower in the pandemic period than before. • The most significant differences observed in the use of healthcare procedures were the reduction of CVC days, the reduced use of antibiotics before surgery, and that of proton pump inhibitors during the pandemic compared with previously.

Identifiants

pubmed: 37582826
doi: 10.1007/s00431-023-05144-4
pii: 10.1007/s00431-023-05144-4
doi:

Substances chimiques

Proton Pump Inhibitors 0
Anti-Bacterial Agents 0

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4859-4866

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Baker MA, Sands KE, Huang SS, Kleinman K, Septimus EJ, Varma N et al (2022) The impact of coronavirus disease 2019 (COVID-19) on healthcare-associated infections. Clin Infect Dis 74:1748–1754. https://doi.org/10.1093/cid/ciab688
doi: 10.1093/cid/ciab688 pubmed: 34370014
Catré D, Lopes MF, Madrigal A, Oliveiros B, Viana JS, Cabrita AS (2013) Early mortality after neonatal surgery: analysis of risk factors in an optimized health care system for the surgical newborn. Rev Bras Epidemiol 16:943–952. https://doi.org/10.1590/S1415-790X2013000400014
doi: 10.1590/S1415-790X2013000400014 pubmed: 24896599
Jacob J, Kamitsuka M, Clark RH, Kelleher AS, Spitzer AR (2015) Etiologies of NICU deaths. Pediatrics 135:e59-65. https://doi.org/10.1542/peds.2014-2967
doi: 10.1542/peds.2014-2967 pubmed: 25489010
Giannoni E, Agyeman PKA, Stocker M, Posfay-Barbe KM, Heininger U, Spycher BD et al (2018) Neonatal sepsis of early onset, and hospital-acquired and community-acquired late onset: a prospective population-based cohort study. J Pediatr 201:106-114.e4. https://doi.org/10.1016/j.jpeds.2018.05.048
doi: 10.1016/j.jpeds.2018.05.048 pubmed: 30054165
De Rose DU, Auriti C, Landolfo F, Capolupo I, Salvatori G, Ranno S et al (2021) Reshaping neonatal intensive care units (NICUs) to avoid the spread of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) to high-risk infants. Infect Control Hosp Epidemiol 42:632–633. https://doi.org/10.1017/ice.2020.310
doi: 10.1017/ice.2020.310 pubmed: 32576333
Indrio F, Salatto A, Amato O, Bartoli F, Capasso L, Corvaglia L et al (2022) COVID-19 pandemic in the neonatal intensive care unit: any effect on late-onset sepsis and necrotizing enterocolitis? Eur J Pediatr 181:853–857. https://doi.org/10.1007/s00431-021-04254-1
doi: 10.1007/s00431-021-04254-1 pubmed: 34490508
Auriti C, De Rose DU, Santisi A, Martini L, Ronchetti MP, Ravà L et al (2022) Incidence and risk factors of bacterial sepsis and invasive fungal infection in neonates and infants requiring major surgery: an Italian multicentre prospective study. J Hosp Infect 130:122–130. https://doi.org/10.1016/j.jhin.2022.09.018
doi: 10.1016/j.jhin.2022.09.018 pubmed: 36202186
Manzoni P, Farina D, Leonessa M, Priolo C, Arisio R, Gomirato G (2007) Type and number of sites colonized by fungi and risk of progression to invasive fungal infection in preterm neonates in neonatal intensive care unit. J Perinat Med 35:220–226. https://doi.org/10.1515/JPM.2007.055
doi: 10.1515/JPM.2007.055 pubmed: 17378718
Kaufman DA, Gurka MJ, Hazen KC, Boyle R, Robinson M, Grossman LB (2006) Patterns of fungal colonization in preterm infants weighing less than 1000 grams at birth. Pediatr Infect Dis J 25:733–737. https://doi.org/10.1097/01.inf.0000226978.96218.e6
doi: 10.1097/01.inf.0000226978.96218.e6 pubmed: 16874174
De Rose DU, Santisi A, Ronchetti MP, Martini L, Serafini L, Betta P et al (2021) Invasive candida infections in neonates after major surgery: current evidence and new directions. Pathogens 10:1–18. https://doi.org/10.3390/pathogens10030319
doi: 10.3390/pathogens10030319
Clements KE, Fisher M, Quaye K, O’Donnell R, Whyte C, Horgan MJ (2016) Surgical site infections in the NICU. J Pediatr Surg 51:1405–1408. https://doi.org/10.1016/j.jpedsurg.2016.04.002
doi: 10.1016/j.jpedsurg.2016.04.002 pubmed: 27132541
De Curtis M, Villani L, Polo A (2021) Increase of stillbirth and decrease of late preterm infants during the COVID-19 pandemic lockdown. Arch Dis Child Fetal Neonatal Ed 106:F456. https://doi.org/10.1136/archdischild-2020-320682
doi: 10.1136/archdischild-2020-320682
Pasternak B, Neovius M, Soderling J, Ahlberg M, Norman M, Ludvigsson JF et al (2021) Preterm birth and stillbirth during the COVID-19 pandemic in Sweden: a nationwide cohort study. Ann Intern Med 174:873–875
doi: 10.7326/M20-6367 pubmed: 33428442
Hedermann G, Hedley PL, Bækvad-Hansen M, Hjalgrim H, Rostgaard K, Poorisrisak P et al (2021) Danish premature birth rates during the COVID-19 lockdown. Arch Dis Child Fetal Neonatal Ed 106:F93–F95. https://doi.org/10.1136/archdischild-2020-319990
doi: 10.1136/archdischild-2020-319990
Been JV, Burgos Ochoa L, Bertens LC, Schoenmakers S, Steegers EA, Reiss IK (2020) Impact of COVID-19 mitigation measures on the incidence of preterm birth: a national quasi-experimental study. Lancet Public Health 5:e604–e611. https://doi.org/10.1016/S2468-2667(20)30223-1
doi: 10.1016/S2468-2667(20)30223-1 pubmed: 33065022 pmcid: 7553867
Choudhary R, Kumari V (2021) COVID-19 and preterm birth – authors’ reply. Lancet Glob Health 9:e118. https://doi.org/10.1016/S2214-109X(20)30458-7
Terrin G, Canani RB, Passariello A, Caoci S, De Curtis M (2012) Inhibitors of gastric acid secretion drugs increase neonatal morbidity and mortality. J Matern Fetal Neonatal Med 25:77–79. https://doi.org/10.3109/14767058.2012.714975
doi: 10.3109/14767058.2012.714975
Manzoni P, García Sánchez R, Meyer M, Stolfi I, Pugni L, Messner H et al (2018) Exposure to gastric acid inhibitors increases the risk of infection in preterm very low birth weight infants but concomitant administration of lactoferrin counteracts this effect. J Pediatr 193:62-67.e1. https://doi.org/10.1016/j.jpeds.2017.09.080
doi: 10.1016/j.jpeds.2017.09.080 pubmed: 29198543
Esaiassen E, Fjalstad JW, Juvet LK, Van den Anker JN, Klingenberg C (2017) Antibiotic exposure in neonates and early adverse outcomes: a systematic review and meta-analysis. J Antimicrob Chemother 72:1858–1870. https://doi.org/10.1093/jac/dkx088
doi: 10.1093/jac/dkx088 pubmed: 28369594
Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O’Grady NP et al (2009) Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 49:1–45. https://doi.org/10.1086/599376
doi: 10.1086/599376 pubmed: 19489710
Gominet M, Compain F, Beloin C, Lebeaux D (2017) Central venous catheters and biofilms: where do we stand in 2017? APMIS 125:365–375. https://doi.org/10.1111/apm.12665
doi: 10.1111/apm.12665 pubmed: 28407421
Cantey JB, Patel SJ (2014) Antimicrobial stewardship in the NICU. Infect Dis Clin North Am 28:247–261. https://doi.org/10.1016/j.idc.2014.01.005

Auteurs

Domenico Umberto De Rose (DU)

Neonatal Intensive Care Unit, "Bambino Gesù" Children's Hospital IRCCS, Piazza S. Onofrio 4, 00165, Rome, Italy. domenico.derose@opbg.net.
PhD Course in Microbiology, Immunology, Infectious Diseases and Transplants (MIMIT), University of Rome "Tor Vergata", Rome, Italy. domenico.derose@opbg.net.

Alessandra Santisi (A)

Neonatal Intensive Care Unit, "Bambino Gesù" Children's Hospital IRCCS, Piazza S. Onofrio 4, 00165, Rome, Italy.

Maria Paola Ronchetti (MP)

Neonatal Intensive Care Unit, "Bambino Gesù" Children's Hospital IRCCS, Piazza S. Onofrio 4, 00165, Rome, Italy.

Ludovica Martini (L)

Neonatal Intensive Care Unit, "Bambino Gesù" Children's Hospital IRCCS, Piazza S. Onofrio 4, 00165, Rome, Italy.

Lisa Serafini (L)

Neonatal Intensive Care Unit, Department of Critical Care Medicine, Anna Meyer University Children's Hospital, Florence, Italy.

Pasqua Betta (P)

Neonatal Intensive Care Unit, Azienda Ospedaliera-Universitaria "Policlinico Gaspare Rodolico", Catania, Italy.

Marzia Maino (M)

Department of Neonatology, "Giovanni XXIII" Hospital, Bergamo, Italy.

Francesco Cavigioli (F)

Neonatology Unit, ASST FBF-Sacco-Buzzi, Ospedale Dei Bambini "Vittore Buzzi", Milan, Italy.

Mario Giuffré (M)

Department of Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Medical Specialties "G. D'Alessandro", University of Palermo, Palermo, Italy.

Elvira Bonanno (E)

Neonatology Unit, Azienda Ospedaliera "SS. Annunziata", Cosenza, Italy.

Chryssoula Tzialla (C)

Neonatal Unit and Neonatal Intensive Care Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Jenny Bua (J)

Neonatal Intensive Care Unit, Institute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste, Italy.

Lorenza Pugni (L)

Neonatal Intensive Care Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Benedetta Della Torre (B)

Neonatal Intensive Care Unit, Azienda Ospedaliera S. Maria Della Misericordia, Perugia, Italy.

Giovanna Nardella (G)

Neonatal Intensive Care Unit, Azienda Ospedaliero-Universitaria "Ospedali Riuniti", Foggia, Italy.

Danila Mazzeo (D)

Neonatology Unit, Policlinico "Gaetano Martino", Messina, Italy.

Lucilla Ravà (L)

Clinical Epidemiology Unit, Bambino Gesù" Children's Hospital IRCCS, Rome, Italy.

Pietro Bagolan (P)

Neonatal Surgery Unit, Bambino Gesù" Children's Hospital IRCCS, Rome, Italy.
Department of Systems Medicine, University of Rome "Tor Vergata", Rome, Italy.

Andrea Dotta (A)

Neonatal Intensive Care Unit, "Bambino Gesù" Children's Hospital IRCCS, Piazza S. Onofrio 4, 00165, Rome, Italy.

Cinzia Auriti (C)

Neonatal Intensive Care Unit, "Bambino Gesù" Children's Hospital IRCCS, Piazza S. Onofrio 4, 00165, Rome, Italy.
Villa Margherita Private Clinic, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH